SOF/VEL/VOX Results in High SVR12 Rates When Administered for 12 Weeks in DAA-Experienced Patients or for 8 Weeks in DAA-Naïve Patients: an Integrated Analysis of the POLARIS-1, POLARIS-2, POLARIS-3, and POLARIS-4 Studies

Press/Media: Press / Media

PeriodApr 25 2017

Media coverage

1

Media coverage

  • TitleSOF/VEL/VOX Results in High SVR12 Rates When Administered for 12 Weeks in DAA-Experienced Patients or for 8 Weeks in DAA-Naïve Patients: an Integrated Analysis of the POLARIS-1, POLARIS-2, POLARIS-3, and POLARIS-4 Studies
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date4/25/17
    PersonsEric J Lawitz